Minimum between doses: 48 hours Flexibility window: Up to 2 days early or 2 days late Missed dose window: 5 days (Ozempic), varies (Wegovy) One day early risk level: Very low If you are using compounded semaglutide , the same timing rules apply
GLP-1 receptor agonists such as semaglutide can help manage blood glucose, body weight, and certain cardiometabolic risks when prescribed for an appropriate patient
MSSPT technology
Regulatory submissions to the MHRA may occur after successful completion
Its important to communicate regularly with your healthcare provider when you begin semaglutide treatment
The most commonly reported side effects in the Phase 2 trial were gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, which were generally mild to moderate and most prominent during dose escalation